SCOPUS 정보 검색 플랫폼

Volumn 50, Issue 2, 2001, Pages 82-86

Long-term/treatment with low doses of interleukin-2 and interferon-α: Immunological effects in advanced renal cell cancer

(4) Andrulli, Simeone b Santi, Rosaria a Majori, Maria a Buzio, Carlo a

a UNIVERSITY OF PARMA (Italy)

b A MANZONI HOSPITAL (Italy)

Author keywords

Immunotherapy; Interferon ; Interleukin 2; Natural killer lymphocytes; Renal cell cancel

Indexed keywords

INTERLEUKIN 2 RECEPTOR; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT INTERLEUKIN 2;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; KIDNEY CANCER; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD56; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED;

EID: 0035023268 PISSN: 03407004 EISSN: None Source Type: Journal
DOI: 10.1007/s002620100175 Document Type: Article

Times cited : (22)

References (12)

1
- 0030798858
- Effectiveness of very low doses of immunotherapy in advanced renal cell cancer
- (1997) Br J Cancer , vol.76 , pp. 541-544
- Buzio, C.¹ De Palma, G.² Passalacqua, R.³ Potenzoni, D.⁴ Ferrozzi, F.⁵ Cattabiani, M.A.⁶ Manenti, L.⁷ Borghetti, A.⁸

2
- 0027717736
- Low dose recombinant interleukin-2 therapy: Rationale and potential clinical applications
- (1993) Semin Oncol , vol.20 , Issue.SUPPL. 9 , pp. 3-10
- Caligiuri, M.A.¹

3
- 0031416082
- Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies
- (1997) Cancer J Sci Am , vol.3 , Issue.SUPPL. 1 , pp. 48-53
- Fefer, A.¹ Robinson, N.² Benyunes, M.C.³ Bensinger, W.I.⁴ Press, O.⁵ Thompson, J.A.⁶ Lindgren, C.⁷

4
- 0033074437
- Renal cell carcinoma: Management of advanced disease
- (1999) J Urol , vol.161 , pp. 381-387
- Figlin, R.A.¹

5
- 0027985315
- Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-α
- (1994) Eur J Cancer , vol.30 A , pp. 1310-1314
- Fossa, S.D.¹ Kramar, A.² Droz, J.P.³

6
- 0031406299
- Immunotherapy with low dose interleukin-2: Rationale for prevention of immune-deficiency-associated cancer
- (1997) Cancer J Sci Am , vol.3 , Issue.SUPPL. 1
- Khatri, V.P.¹ Baiocchi, R.A.² Bernstein, Z.P.³ Caligiuri, M.A.⁴

7
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.² Staquet, M.³ Winkler, A.⁴

8
- 0025824067
- Comparative studies of CD3+ CD56+ cells: Examination of morphology, function, T cells receptor rearrangement, and pore-forming protein expression
- (1991) Cellular Immunol , vol.136 , pp. 486-495
- Ortaldo, J.R.¹ Winkler-Pickett, R.T.² Yagita, H.³ Young, H.A.⁴

9
- 0026725212
- Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2
- (1992) Ann Oncol , vol.3 , pp. 475-480
- Palmer, P.A.¹ Vinke, J.² Philip, T.³ Negrier, S.⁴ Atzpodien, J.⁵ Kirchner, H.⁶ Oskam, R.⁷ Franks, C.R.⁸

10
- 0030294654
- Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2
- (1996) J Immunol , vol.157 , pp. 3886-3892
- Satoh, M.¹ Seki, S.² Hashimoto, W.³ Ogasawara, K.⁴ Kobayashi, T.⁵ Kumagai, K.⁶ Matsuno, S.⁷ Takeda, K.⁸

11
- 0031415888
- Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells
- (1997) Cancer J Sci Am , vol.3 , Issue.SUPPL. 1 , pp. 54-58
- Van Besien, K.¹ Margolin, K.² Champlin, R.³ Forman, S.⁴

12
- 0032580508
- Metastatic renal cell carcinoma: What causes occasional dramatic regressions?
- (1998) N Engl J Med , vol.338 , pp. 1305-1306
- Young, R.C.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.